ABSTRACT
AIMS OF THE STUDY: To study the epidemiologic, clinical, therapeutic and prognostic characteristics of the myocardial infarction (MI) in patients with chronic kidney disease (CKD). To identify the impact of CKD in hospital, mid- and long-term survival after myocardial infarction. To determine the predictive factors of hospital and midterm MACCE in patients with CKD. PATIENTS AND METHODS: The study population was 231 patients with a myocardial infarction admitted alive from January 2005 to December 2006. The population was divided into two groups. Group 1: glomerular filtration rate (GFR) ≥60 ml/min: 112 patients; group 2: GFR<60 ml/min: 119 patients. RESULTS: Patients with CKD had more history of stroke and arterial hypertension. They had received less medical therapies and urgent reperfusion. In multivariate analysis, CKD was a predictive factor of hospital (P=0.016), at 6 months (P=0.003), at 1 year (P=0.004) and at 2 years MACCE (P=0,015). The predictive factors of hospital MACCE in group 2 were: use of vasopressors (P=0.001) and primary angioplasty (P=0.043). In patients with CKD, only surgical coronary revascularization was MACCE predictive factor (P=0.03). CONCLUSION: Baseline renal function is a powerful predictor of short- and long-term events after myocardial infarction. Our results confirm the need to include the renal function in the evaluation of the level of risk among patients admitted with acute myocardial infarction.
Subject(s)
Kidney Failure, Chronic/mortality , Kidney Failure, Chronic/therapy , Myocardial Infarction/mortality , Myocardial Infarction/therapy , Adult , Aged , Aged, 80 and over , Comorbidity , Creatinine/blood , Cross-Sectional Studies , Female , France , Hospital Mortality , Humans , Kidney Failure, Chronic/diagnosis , Male , Middle Aged , Myocardial Infarction/diagnosis , Prognosis , Reference Values , Risk Factors , Survival RateABSTRACT
Supraventricular tachycardia in infants are variable. We try to summarize clinical, electrical and treatment particularities of supraventricular arrhythmia in infants. The majority of infants with supraventricular arrhythmia have a good clinical outcome and an excellent prognosis and may not require chronic antiarrhythmic therapy if they had precocious treatment.
Subject(s)
Tachycardia, Supraventricular/therapy , Algorithms , Amiodarone/therapeutic use , Anti-Arrhythmia Agents/therapeutic use , Atrial Flutter/congenital , Atrial Flutter/diagnosis , Atrial Flutter/therapy , Catheter Ablation , Decision Support Techniques , Electric Countershock , Electrocardiography , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Male , Signal Processing, Computer-Assisted , Tachycardia, Supraventricular/congenital , Tachycardia, Supraventricular/diagnosisABSTRACT
A 45 day old new-born with arrhythmia-induced cardiomyopathy complicated by thrombus formation is presented. Drug treatment produced immediate symptomatic relief and subsequent reversion to normal cardiac function. The thrombus disappeared a few days later.
